Takeda to Acquire Maverick Therapeutics to Advance T-Cell Engager Therapies for Solid Tumors and Expand Novel Immuno-Oncology Portfolio

Takeda Media Contacts:?
Japanese Media Kazumi Kobayashi kazumi.kobayashi@takeda.com +81 (0) 3-3278-2095 | Media outside Japan Chris Stamm chris.stamm@takeda.com +1 (617) 347-7726 |
Investor Inquiries Kristen Hawley khawley@mavericktx.com +1 (650) 443-7549 | Media Inquiries Peg Rusconi prusconi@vergescientific.com +1 (617) 910-6217 |